The strong performance of the osteoporosis therapeutics market is expected to continue, with forecasters predicting it to grow at a CAGR of 7.7% between 2010 and 2018.
The global osteoporosis therapeutics market is anticipated to reach $10 billion by 2017. The main factors driving osteoporosis therapeutics market growth include the aging population worldwide, growing awareness of the disease, and development and introduction of novel therapeutics.
Osteoporosis represents a relentless epidemic growing swiftly across regions such as North America, Europe, and Japan. As per International Osteoporosis Foundation census, more than 200 million people in the world are affected by osteoporosis, of which about 80% are women.
The US represents the largest region within the osteoporosis therapeutics market on a global scale. Until recently, pharmaceutical companies in the US paid limited attention to osteoporosis therapeutics, but now are scrambling for a share of what is turning in to an enormous market.
The European osteoporosis therapeutics market trails behind the US. Limited awareness on osteoporosis and restricted availability of diagnostic equipment form the key factors plaguing the growth of the osteoporosis therapeutics market in Europe.
The osteoporosis therapeutics market provides several opportunities for existing as well as future companies. However, increase in cost pressure due to generic penetration is a major barrier for companies to enter the market.
For more information on the osteoporosis therapeutics market, see the latest research: Osteoporosis Therapeutics Market Report
Follow us on Twitter @CandMResearch
Companiesandmarkets.com issues news updates and report summaries covering all major industries and sectors. The service provides additional client monitoring and timely alerts to breaking industry and sector news leading the day's business headlines. News articles, written by our staff, contain additional analyst insight, providing value added insight for our readers. News updates and real-time alerts on newly-released market reports are also available from our Facebook page, Twitter feed @CandMResearch and RSS links. We also welcome inquiries from business journalists and the news media.